DK2895867T3 - Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf - Google Patents
Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf Download PDFInfo
- Publication number
- DK2895867T3 DK2895867T3 DK13776426.2T DK13776426T DK2895867T3 DK 2895867 T3 DK2895867 T3 DK 2895867T3 DK 13776426 T DK13776426 T DK 13776426T DK 2895867 T3 DK2895867 T3 DK 2895867T3
- Authority
- DK
- Denmark
- Prior art keywords
- enantiomes
- unknown
- peptides derived
- peptides
- derived
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012108598.6A DE102012108598A1 (de) | 2012-09-14 | 2012-09-14 | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
PCT/EP2013/068992 WO2014041115A2 (de) | 2012-09-14 | 2013-09-13 | Neue, von d3 abgeleitete d-enantiomere peptide und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2895867T3 true DK2895867T3 (da) | 2020-02-03 |
Family
ID=49354628
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17172220.0T DK3346273T3 (da) | 2012-09-14 | 2013-09-13 | Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf |
DK13776426.2T DK2895867T3 (da) | 2012-09-14 | 2013-09-13 | Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17172220.0T DK3346273T3 (da) | 2012-09-14 | 2013-09-13 | Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf |
Country Status (9)
Country | Link |
---|---|
US (3) | US20150307552A1 (da) |
EP (2) | EP2895867B1 (da) |
JP (2) | JP6345670B2 (da) |
CN (2) | CN104704371B (da) |
DE (1) | DE102012108598A1 (da) |
DK (2) | DK3346273T3 (da) |
ES (2) | ES2768264T3 (da) |
PL (1) | PL3346273T3 (da) |
WO (1) | WO2014041115A2 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
DE102015003676A1 (de) | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH Fachbereich Patente | Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz |
DE102015003503A1 (de) * | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH | Spezifisch Amyloid-Beta bindende Peptide und deren Verwendung für die Therapie und Diagnose der Alzheimerschen Demenz |
DE102016125645A1 (de) * | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz |
WO2019070645A1 (en) * | 2017-10-02 | 2019-04-11 | Cedars-Sinai Medical Center | METHODS AND COMPOSITIONS FOR EFFECTIVE ADMINISTRATION THROUGH MULTIPLE BIOLOGICAL BARRIERS |
DE102021121435A1 (de) * | 2021-08-18 | 2023-02-23 | Priavoid Gmbh | Aß-BINDENDE SUBSTANZEN |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1346041T3 (da) | 2000-11-27 | 2007-07-02 | Praecis Pharm Inc | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom |
WO2002081515A1 (fr) * | 2001-04-03 | 2002-10-17 | Kyowa Hakko Kogyo Co., Ltd. | Proteine de liaison de facteur de croissance de type insuline |
DE10117281A1 (de) | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
US20050158306A1 (en) * | 2004-01-16 | 2005-07-21 | Halikas James A. | Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies |
AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
US20070092508A1 (en) * | 2005-10-21 | 2007-04-26 | Recombiant Technologies, Llc | Detoxification depot for Alzheimer's disease |
US8445438B2 (en) | 2008-10-27 | 2013-05-21 | Recombinant Technologies Llc | Compositions comprising capture peptides for A β-amyloid peptide |
DE102008037564A1 (de) * | 2008-11-19 | 2010-05-20 | Forschungszentrum Jülich GmbH | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
DE102010017130B4 (de) | 2010-05-28 | 2018-11-29 | Forschungszentrum Jülich GmbH | Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung |
WO2013150127A2 (de) * | 2012-04-05 | 2013-10-10 | Forschungszentrum Jülich GmbH | Polymere, enthaltend multivalente amyloid-beta-bindende d-peptide und deren verwendung |
US9591845B2 (en) * | 2012-04-05 | 2017-03-14 | Forschungszentrum Juelich Gmbh | Method for treating blood, blood products and organs |
DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
-
2012
- 2012-09-14 DE DE102012108598.6A patent/DE102012108598A1/de not_active Withdrawn
-
2013
- 2013-09-13 WO PCT/EP2013/068992 patent/WO2014041115A2/de active Application Filing
- 2013-09-13 US US14/426,797 patent/US20150307552A1/en not_active Abandoned
- 2013-09-13 ES ES13776426T patent/ES2768264T3/es active Active
- 2013-09-13 PL PL17172220.0T patent/PL3346273T3/pl unknown
- 2013-09-13 EP EP13776426.2A patent/EP2895867B1/de active Active
- 2013-09-13 DK DK17172220.0T patent/DK3346273T3/da active
- 2013-09-13 CN CN201380047981.9A patent/CN104704371B/zh active Active
- 2013-09-13 DK DK13776426.2T patent/DK2895867T3/da active
- 2013-09-13 ES ES17172220T patent/ES2938773T3/es active Active
- 2013-09-13 EP EP17172220.0A patent/EP3346273B1/de active Active
- 2013-09-13 CN CN201710944015.7A patent/CN107556375A/zh active Pending
- 2013-09-13 JP JP2015531567A patent/JP6345670B2/ja active Active
-
2017
- 2017-04-10 US US15/482,968 patent/US10167318B2/en not_active Expired - Fee Related
-
2018
- 2018-05-23 JP JP2018098517A patent/JP6611858B2/ja active Active
- 2018-11-27 US US16/200,820 patent/US10889618B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10889618B2 (en) | 2021-01-12 |
PL3346273T3 (pl) | 2023-04-11 |
EP2895867B1 (de) | 2019-10-23 |
EP3346273B1 (de) | 2023-01-04 |
CN104704371B (zh) | 2017-11-07 |
WO2014041115A2 (de) | 2014-03-20 |
US10167318B2 (en) | 2019-01-01 |
JP2018141008A (ja) | 2018-09-13 |
CN104704371A (zh) | 2015-06-10 |
JP6345670B2 (ja) | 2018-06-20 |
JP2015531348A (ja) | 2015-11-02 |
WO2014041115A3 (de) | 2014-06-26 |
EP2895867A2 (de) | 2015-07-22 |
JP6611858B2 (ja) | 2019-11-27 |
CN107556375A (zh) | 2018-01-09 |
US20170313744A1 (en) | 2017-11-02 |
EP3346273A8 (de) | 2018-08-29 |
DK3346273T3 (da) | 2023-02-27 |
EP3346273A1 (de) | 2018-07-11 |
ES2768264T3 (es) | 2020-06-22 |
ES2938773T3 (es) | 2023-04-14 |
US20150307552A1 (en) | 2015-10-29 |
DE102012108598A1 (de) | 2014-04-10 |
US20190085030A1 (en) | 2019-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2895100T3 (da) | Digital bideskinne | |
DK2914291T3 (da) | Anti-komplement-c1s-antistoffer og anvendelser deraf | |
DK3195844T3 (da) | Ganghjælpeindretning | |
DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
DK2920197T3 (da) | Prolinlåste sammenhæftede peptider og anvendelser deraf | |
DK3725778T3 (da) | Formuleringer af enzalutamid | |
DK3055811T3 (da) | Bærbar sportstidtagningsmærkeenhed | |
DK2970954T3 (da) | Modifikation af polypeptider | |
DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
DK3293183T3 (da) | Hæmmerforbindelser | |
DK3363805T3 (da) | Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner | |
DE102013100635A8 (de) | Benutzer-Identifikation | |
BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
FI10272U1 (fi) | Harjoittelualusta | |
DK3453723T3 (da) | Anti-ASIC1-antistoffer og anvendelser deraf | |
FR3014969B1 (fr) | Fixation temporaire | |
DK2895867T3 (da) | Hidtil ukendte d-enantiomer peptider afledt af d3 og anvendelse deraf | |
DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf | |
DK2702756T3 (da) | Bærbart kamera | |
DK2914286T3 (da) | Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf | |
DK2880164T3 (da) | Glykoproteinhormon langstidsvirkende superagonister | |
FR2998538B1 (fr) | Trampoline amphibie | |
DK2723873T4 (da) | P0-gen-nedreguleringskonstruktioner og anvendelse deraf |